Sign In
Buy AKTX
$14.99
+0.355 (+2.43%)
At Close: Jun 03, 2026
Old Port building owner says he regrets hiring armed guards
02:25am, Saturday, 06'th Jun 2020
The owner of a building on Middle Street hired 2 armed guards after businesses were damaged or burglarized the previous night.
All the Potential Treatments and Vaccines for COVID-19 | Digital Trends
01:00pm, Saturday, 30'th May 2020
Institutions around the world are working to find treatments and vaccines for COVID-19, the novel coronavirus. The pathway is a long and difficult one.
Akari Therapeutics Reports First Quarter 2020 Financial Results and Highlights Recent Clinical Progress
11:00am, Friday, 29'th May 2020
Open pivotal study in pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) with orphan and fast track approval Preparing for pivotal study.
Akari Therapeutics Receives Positive EMA Opinion on Orphan Designation for Nomacopan for Bullous Pemphigoid
03:32pm, Thursday, 21'st May 2020
Akari Therapeutics, Plc (AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement (C5) and/or leukotriene (LTB4)
Alexion Announces Upcoming Data Presentations at the Virtual 25th Congress of the European Hematology Association
12:00am, Thursday, 14'th May 2020
Alexion Announces Upcoming Data Presentations at the Virtual 25th Congress of the European Hematology Association
Global Paroxysmal Nocturnal Hemoglobinuria Market Study 2016-2024 - ResearchAndMarkets.com
12:00am, Tuesday, 12'th May 2020
The
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
Akari Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
02:47pm, Tuesday, 05'th May 2020
Akari announced positive top line Phase 2 data. Athersys progresses with multistem COVID-19 therapy. SCWorx announces cancellation of COVID-19 test kit order.
Akari Therapeutics to Participate in STRH Life Sciences Virtual Meeting Series
11:30am, Monday, 04'th May 2020
Akari Therapeutics, Plc (AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement (C5) and/or leukotriene (LTB4) syst
Akari Therapeutics (AKTX) Gets a Buy Rating from B.Riley FBR
04:16pm, Friday, 01'st May 2020
B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on Akari Therapeutics (AKTX – Research Report) today and set a
Study achieved primary endpoint of no drug-related serious adverse events and main secondary efficacy endpoints with 7 of the 9 treated patients showing a rapid and clinically.
B.Riley FBR Thinks Akari Therapeutics’ Stock is Going to Recover
06:38am, Thursday, 02'nd Apr 2020
B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on Akari Therapeutics (AKTX – Research Report) today and set a
Akari Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Business Highlights
12:00pm, Tuesday, 31'st Mar 2020
Significant Clinical Progress Across Target Indications during 2019 and 2020 Year-to-Date - Interim Phase II bullous pemphigoid (BP) data demonstrated a rapid and.
On Wednesday, shares of Akari Therapeutics, Plc (NASDAQ:AKTX) reached at $1.22 price level during last trade its distance from 20 days simple moving average was [...]
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 16.) * BioNTech SE - ADR (NASDAQ: BNTX) (announced eff
